Slava Akmaev, Ph.D., Senior Vice President and Chief Analytics Officer at BERG presented at the Precision Medicine World Conference 2016.
Artificial Intelligence in Drug Development: Case Studies
The current paradigm in discovery and development of novel therapeutics is outdated and inefficient. Here, we present a radically different approach that relies on hypothesis free, data-driven methodology in biological research. Berg Interrogative Biology® and artificial intelligence mathematics are readily available for the processing of disparate biological outputs into actionable research leads. Slava discussed target and biomarker case studies in oncology, endocrinology and neurology.
You can watch Slava’s presentation here: https://vimeo.com/156680844